Filius Bart Insider Trading Activity (PRQR)

Summary

Updated Jul 16, 2026

Filius Bart has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $231K.

Profile

Filius Bart is listed as a director of ProQR Therapeutics N.V. in SEC filings dated up to 2026-06-30. Public biographical information about Filius Bart beyond this SEC disclosure is not readily available in widely accessible sources, and there is no independently verifiable record of education, career history, or other roles tied to this individual from the materials reviewed. The available context identifies Filius Bart solely as a director for ProQR Therapeutics N.V. as of the 2026 filing date.

Role	Director
Notability	20/100

Board memberships

ProQR Therapeutics N.V.

Awards & honors

Public director role at ProQR Therapeutics N.V. as of 2026-06-30
No additional publicly documented achievements found in SEC filings or standard public references

Date	Ticker	Company	Code	Shares	Price	Value
2026-06-30	PRQR	ProQR Therapeutics N.V.	P — Open-market purchase	150.0K	$1.54	$231K

Frequently Asked Questions

Who is Filius Bart?

How many SEC Form 4 filings has Filius Bart submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Filius Bart been buying or selling stock?

Recorded transactions: 1 open-market purchases ($231K) and 0 open-market sales () across all tracked filings.

Where can I see all of Filius Bart's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Filius Bart — SEC Form 4 Insider Trading Activity